Share This Page
Drug Price Trends for DIBUCAINE
✉ Email this page to a colleague
Average Pharmacy Cost for DIBUCAINE
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| DIBUCAINE 1% OINTMENT | 00536-1211-95 | 0.15852 | GM | 2025-04-23 |
| DIBUCAINE 1% OINTMENT | 00536-1211-95 | 0.16072 | GM | 2025-03-19 |
| DIBUCAINE 1% OINTMENT | 00536-1211-95 | 0.16053 | GM | 2025-02-19 |
| DIBUCAINE 1% OINTMENT | 00536-1211-95 | 0.15691 | GM | 2025-01-22 |
| DIBUCAINE 1% OINTMENT | 00536-1211-95 | 0.15145 | GM | 2024-12-18 |
| DIBUCAINE 1% OINTMENT | 00536-1211-95 | 0.15179 | GM | 2024-11-20 |
| DIBUCAINE 1% OINTMENT | 00536-1211-95 | 0.14694 | GM | 2024-10-23 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Dibucaine
Introduction to Dibucaine
Dibucaine, a potent local anesthetic, is widely used for its long-lasting analgesic effects, particularly in topical and spinal anesthesia. Here’s a comprehensive analysis of the market trends, growth drivers, and price projections for dibucaine.
Market Size and Growth
The global market for local anesthetic drugs, which includes dibucaine, is experiencing significant growth. While specific figures for dibucaine alone are not readily available, the broader local anesthetic market provides valuable insights.
- The global local anesthesia drugs market was valued at USD 4.01 billion in 2023 and is projected to grow at a CAGR of 3.6% from 2024 to 2030[1].
Segments and Applications
By Type
Dibucaine falls under the category of local anesthetics, which includes other drugs like lidocaine, bupivacaine, and ropivacaine. Each of these has different market shares and growth rates.
- Lidocaine, for instance, dominated the market with a 28.7% share in 2023, while ropivacaine is expected to register the fastest CAGR during the forecast period due to its favorable safety profile and longer duration of action[1].
By Application
Dibucaine is used in various applications, including:
- Topical Anesthesia: Dibucaine is often used in topical formulations for pain relief in conditions such as skin irritations and minor surgical procedures.
- Spinal Anesthesia: It is also used in spinal anesthesia due to its long-lasting effects.
Regional Outlook
The market for local anesthetics, including dibucaine, varies by region:
- North America: This region is a significant market due to the high prevalence of chronic conditions and well-established healthcare infrastructure[3][4].
- Europe: European countries also contribute substantially to the market, driven by increasing surgical volumes and an aging population.
- Asia Pacific: This region is anticipated to grow at the highest CAGR, driven by increasing healthcare expenditure and a growing geriatric population[3][4].
Market Drivers
Several factors drive the growth of the dibucaine market:
- Growing Number of Surgical Operations: The increasing number of surgical procedures, especially in dentistry, cosmetic surgery, and dermatology, fuels the demand for local anesthetics like dibucaine[3].
- Aging Population: The global aging population requires more operations and chronic condition treatments, which increases the use of local anesthetics[3].
- Regulatory Support and Approvals: Regulatory approvals for new formulations and applications, along with favorable reimbursement schemes, promote market growth[3].
Market Restraints
Despite the growth drivers, there are several restraints to consider:
- Price Pressure and Cost Constraints: Pricing pressures in the healthcare industry and financial limitations can impact the adoption of dibucaine products[3].
- Limited Payment Policies: Restrictive payment policies can also hinder market growth by limiting access to these drugs[3].
Competitive Landscape
The market for local anesthetics is competitive, with several key players:
- Pfizer Inc
- AstraZeneca Plc
- Glenmark Pharmaceuticals Ltd
- Teva Pharmaceutical Industries Ltd
- Viatris Inc
- Amneal Pharmaceuticals LLC
- Taro Pharmaceuticals[3].
These companies are involved in continuous research and development to improve existing products and introduce new formulations.
Price Projections
While specific price projections for dibucaine are not available, the overall trend in the local anesthetic market can provide some insights:
- The cost of local anesthetics can vary based on the formulation, application, and region. For instance, lidocaine, a widely used local anesthetic, is projected to grow at a CAGR of 8.5% from 2024 to 2030, reaching a market size of USD 3.5 billion by 2030[3].
- The prices of local anesthetics, including dibucaine, are likely to remain competitive due to market pressures and the need to balance profitability with affordability.
Key Takeaways
- Market Growth: The global local anesthetic market, including dibucaine, is expected to grow steadily driven by increasing surgical volumes and an aging population.
- Regional Variations: North America and Europe are significant markets, while the Asia Pacific region is expected to grow at the highest CAGR.
- Competitive Landscape: The market is competitive with several key players focusing on research and development.
- Price Projections: Prices are expected to remain competitive, with a focus on balancing profitability and affordability.
FAQs
1. What is the primary use of dibucaine in medical procedures? Dibucaine is primarily used for its long-lasting analgesic effects in topical and spinal anesthesia.
2. Which region is expected to grow at the highest CAGR in the local anesthetic market? The Asia Pacific region is anticipated to grow at the highest CAGR due to increasing healthcare expenditure and a growing geriatric population.
3. What are the main drivers of the dibucaine market? The main drivers include the growing number of surgical operations, an aging population, and regulatory support and approvals.
4. Which companies are key players in the local anesthetic market? Key players include Pfizer Inc, AstraZeneca Plc, Glenmark Pharmaceuticals Ltd, Teva Pharmaceutical Industries Ltd, Viatris Inc, Amneal Pharmaceuticals LLC, and Taro Pharmaceuticals.
5. How does the pricing of dibucaine compare to other local anesthetics? The pricing of dibucaine is likely to remain competitive, similar to other local anesthetics, due to market pressures and the need to balance profitability with affordability.
Sources
- Grand View Research - Local Anesthesia Drugs Market Size & Share Report, 2030
- Global Market Vision - Global Dibucaine Hydrochloride Market Recent Trends, In-depth Analysis
- Verified Market Research - In-Depth Industry Outlook: Lidocaine Market Size, Forecast
- Allied Market Research - Pharmaceutical Suppositories Market Size, Share, Growth - 2035
More… ↓
